Eric Van Cutsem - Concepedia

Author

Eric Van Cutsem

Also Known As

A M Stone, Cutsem, Eric Van, E Van Cutsem, E van Cutsem, E. Van Cutsem, E. van Cutsem, Eric Cutsem, Eric Van Cutsem, Eric Van Cutsem, Eric van Cutsem

1.8K

Publications

171.9K

Citations

174

H-Index

208

Concepts

All Affiliations

KU Leuven Universitair Ziekenhuis Leuven National Cancer Center Hospital East Vall d'Hebron Hospital Universitari Memorial Sloan Kettering Cancer Center

About

Eric Van Cutsem is an author at KU Leuven specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	108	454	72.3K
2	Health Sciences	53	149	12.8K
3	Engineering	7	7	471
4	Natural Sciences	2	2	274
5	Nursing	1	1	65

Eric Van Cutsem

724

Publications

156.5K

Citations

166

H-Index

Page 1

	Year	Citations
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova, The Lancet Surgical OncologyChemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterology	2010	7.2K
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, New England Journal of Medicine	2013	6.5K
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer David Cunningham, Yves Humblet, Salvatore Siena, New England Journal of Medicine	2004	5K
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, New England Journal of Medicine	2009	3.8K
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Eric Van Cutsem, Andrés Cervantes, René Adam, Annals of Oncology Surgical OncologyEsmo Consensus GuidelinesGastrointestinal OncologyMedicineCancer Management	2016	3.3K
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Journal of Clinical Oncology	2008	3.1K
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, New England Journal of Medicine	2017	3K
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Axel Grothey, Eric Van Cutsem, Alberto Sobrero, The Lancet OncologyGastrointestinal OncologyRegorafenib MonotherapyClinical TrialsColorectal Cancer	2012	2.8K
Everolimus for Advanced Pancreatic Neuroendocrine Tumors James C. Yao, Manisha H. Shah, Tetsuhide Ito, New England Journal of Medicine	2011	2.8K
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer Thierry André, Kai‐Keen Shiu, Tae Won Kim, New England Journal of Medicine	2020	2.8K

Page 1